NCT07862244 · NOT YET RECRUITING

A Grief Support App for Adults Experiencing Bereavement

This trial tests a self-guided phone app called Daybreak for bereaved adults. It offers grief information, writing exercises, a memory space, and twice-daily check-ins. Researchers will measure grief symptoms and whether people find the app usable and acceptable. Phase is not applicable because this is a behavioral study, not a drug trial. It is an early look at how well the app works.

You may qualify if

  • Aged 18+
  • Fluent in English (reading and writing)
  • GP in the UK
  • Capable of giving informed consent
  • Loss of a loved one at least three months ago
  • Smartphone with access to apple store or google play store

You're excluded if

  • High risk of suicidal intent or self-harm
  • Current psychiatric inpatient stay
  • Current psychological treatment for grief
  • Diagnosis of PGD or PTSD - If loss less than 6 months ago needs to score below clinical cut-off on PG-13-R
  • Severe cognitive impairment or learning difficulties

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-07

View full record on ClinicalTrials.gov

All APOE4 clinical trials